Canopy Growth Corp vs State Street PDR S&P Retail ETF — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while State Street PDR S&P Retail ETF trades at $89.03. The key difference: State Street PDR S&P Retail ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | XRT | |
|---|---|---|
Market Cap | $398.46M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.92 | $90.88 |
52-Week Low | $0.86 | $77.28 |
Enterprise Value | $337.90M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
XRT trades at $87.47, down 0.69% on the day, with technical indicators showing a bullish moving average signal but neutral oscillators. The ETF tracks the retail sector, which faces mixed sentiment amid consumer spending resilience and macroeconomic pressures. Recent news highlights retail sales growth but also concerns over inflation and consumer sentiment.
The outlook for XRT is cautiously optimistic, supported by technical strength and sector exposure, but risks include inflation and weak consumer sentiment. Investment opportunity lies in retail sector recovery, while headwinds from economic conditions pose challenges for near-term performance.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →